VKTX VIKING THERAPEUTICS INC US FDA Inspections 8-K Filing 2023 - Clinical Trial Results Viking Therapeutics announced results from its Phase 1 clinical trial of VK2735.Get access to all SEC 8-K filings of the VIKING THERAPEUTICS INC